Finance

Lists
524606:BOM
Beryl Drugs Ltd
₹25.97
+1.25%
(+0.32) 1D
Oct 1, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524606...
Open
₹25.00
High
₹26.90
Low
₹24.05
Mkt. cap
131.71M
Avg. vol.
2.39K
Volume
4.03K
P/E ratio
20.66
52-wk high
₹27.60
52-wk low
₹15.92
EPS
₹1.26
Open
₹25.00
High
₹26.90
Low
₹24.05
Mkt. cap
131.71M
Avg. vol.
2.39K
Volume
4.03K
P/E ratio
20.66
52-wk high
₹27.60
52-wk low
₹15.92
EPS
₹1.26
News stories
From web sources and news partners
About Beryl Drugs Ltd
CEO-
Employees-
Founded1993
Headquarters-
SectorPharmaceutical industry
Websiteberyldrugs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
51.20M
37.77M
51.29M
72.97M
Cost of goods sold
25.81M
20.37M
34.99M
44.30M
Cost of revenue
25.81M
20.37M
34.99M
44.30M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.77M
7.89M
6.52M
6.31M
Operating expense
21.98M
22.56M
7.12M
25.35M
Total operating expenses
47.80M
42.93M
42.11M
69.65M
Operating income
3.40M
-5.16M
9.18M
3.32M
Other non operating income
-
-
-173.00K
-
EBT including unusual items
2.60M
-6.08M
8.66M
2.70M
EBT excluding unusual items
2.60M
-6.08M
8.66M
2.70M
Income tax expense
2.51M
-4.40M
3.03M
490.00K
Effective tax rate
96.58%
72.41%
35.03%
18.16%
Other operating expenses
12.30M
11.49M
-5.63M
15.88M
Net income
89.00K
-1.68M
5.62M
2.21M
Net profit margin
0.17%
-4.44%
10.97%
3.03%
Earnings per share
-
-
-
-
Interest and investment income
-
-
199.00K
-
Interest expense
-802.00K
-917.00K
-551.00K
-620.00K
Net interest expenses
-802.00K
-917.00K
-352.00K
-620.00K
Depreciation and amortization charges
3.92M
3.18M
4.03M
3.16M
EBITDA
7.27M
-2.05M
12.89M
7.05M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps